Denmark · Funded startup

Who invested in Symphogen

8 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$360Mraised across 8 rounds since 2004, from 8 sources

$25MSeries C$25MSeries D$6.5MVenture$42MGrowth$131MGrowth$54MGrowth$77MDebt
Latest round
Debt, $77MOct 2015
Biggest round
$131MGrowth · Jan 2011
Step-upi
1.4×
Investors
12
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20062008201020122014
$25MSeries C$25MSeries D$6.5MVenture?Round$42MGrowth$131MGrowth$54MGrowth$77MDebt
First round
Series C, $25M
Nov 2004
Biggest round
$131M
Growth · Jan 2011
Usual gap between rounds
16 months
the median of 7

The rounds

  1. Oct 2015
    Debt$77M2 returning

    From a historical funding record

  2. May 2013
    Growth$54M2 new1 returning

    Reported by finsmes.com

  3. Jan 2011
  4. Feb 2009
    Growth$42M1 returning

    Reported by symphogen.com

  5. Jun 2008
    RoundAmount undisclosed1 new

    From a historical funding record

  6. Feb 2007
    Venture$6.5M1 returning

    From a historical funding record

  7. Jan 2006
  8. Nov 2004

Founders and team

From Symphogen's own website: 3 on the team.

  • Christophe ThurieauChief Executive Officer
  • Jane JuelChief Operating Officer
  • Michael HerbstVP, Finance and Procurement

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Novo Holdings A/SGrowth equity5rounds
Gilde HealthcarePrivate equity2rounds
SLS VentureGrowth equity2rounds
LD PensionsInstitutional LP2rounds
The Danish Pension Fund PKAGrowth equity2rounds
VF VentureVC firm1round
Takeda VenturesCorporate VC1round
GenenFUNDVC firm1round
Danica PensionInstitutional LP1round
PKAno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Symphogen

Who invested in Symphogen?

Symphogen's investors include Novo Holdings A/S, Essex Woodlands Healthcare Partners, The Danish Growth Fund, Gilde Healthcare and SLS Venture, and 7 more on record.

How much has Symphogen raised?

Symphogen has raised $360M across 8 rounds since 2004. One round did not disclose an amount, so the total is a floor.

When did Symphogen last raise?

Symphogen's most recent round was a Debt of $77M in Oct 2015.

What was Symphogen's biggest round?

Symphogen's largest round on record is $131M (Growth), in Jan 2011.

Who backed Symphogen first?

Symphogen's first round on record, in Nov 2004, was backed by The Danish Growth Fund, Novo Holdings A/S and Essex Woodlands Healthcare Partners and 2 others.

What stage is Symphogen at?

Symphogen's latest named round is a Debt, in Oct 2015.

Where is Symphogen based?

Symphogen is based in Denmark.

Companies like Symphogen

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.